Drug Profile
Research programme: PPAR modulators - Dong-A ST/Yuhan
Alternative Names: PAM-1616Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Dong-A Pharmaceutical; Yuhan
- Developer Dong-A ST
- Class
- Mechanism of Action Peroxisome proliferator-activated receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Type-2-diabetes-mellitus in South Korea
- 30 Jul 2007 Preclinical trials in Type-2 diabetes mellitus in South Korea (unspecified route)